Charles Schwab Investment Management »

Theravance Biopharma shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Theravance Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Theravance Biopharma held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theravance Biopharma by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.5M 314k 11.24
2023-09-30 $2.8M 328k 8.63
2023-06-30 $4.2M 404k 10.35
2023-03-31 $5.2M 483k 10.85
2022-12-31 $5.8M 516k 11.22
2022-09-30 $5.3M 525k 10.14
2022-06-30 $4.6M 504k 9.06
2022-03-31 $3.9M 403k 9.56
2021-12-31 $4.3M 391k 11.05
2021-09-30 $2.6M 352k 7.40
2021-06-30 $5.2M 357k 14.52
2021-03-31 $6.8M 334k 20.41
2020-12-31 $5.8M 324k 17.77
2020-09-30 $4.6M 314k 14.79
2020-06-30 $6.6M 314k 20.99
2020-03-31 $6.9M 300k 23.11
2019-12-31 $6.9M 268k 25.89
2019-09-30 $5.0M 259k 19.48
2019-06-30 $4.1M 252k 16.33
2019-03-31 $5.4M 239k 22.67
2018-12-31 $6.0M 235k 25.59
2018-09-30 $7.7M 237k 32.67
2018-06-30 $5.1M 226k 22.68
2018-03-31 $5.1M 209k 24.25
2017-12-31 $5.6M 200k 27.89
2017-09-30 $6.6M 192k 34.24
2017-06-30 $7.1M 177k 39.84
2017-03-31 $6.0M 163k 36.82
2016-12-31 $4.6M 146k 31.88
2016-09-30 $4.3M 119k 36.24
2016-06-30 $2.6M 114k 22.69
2016-03-31 $1.6M 84k 18.80
2015-12-31 $1.5M 89k 16.40
2015-09-30 $814k 74k 11.00
2015-06-30 $901k 69k 13.02
2015-03-31 $1.2M 67k 17.36
2014-12-31 $954k 64k 14.93
2014-09-30 $1.4M 62k 23.06
2014-06-30 $1.9M 60k 31.90